Search the Newsreel

Clinic earns grant for AI initiatives

The Cherry Hill Free Clinic has been recognized as a 2026 Champion in Action by Citizens Financial Group, Inc. for its initiatives in building AI readiness. This recognition includes a $50,000 grant, volunteer support, and promotional assistance, which will be used to implement Clinic …

BlackRock, Inc. Expands Stake in Zentalis Pharmaceuticals (ZNTL) with Strategic Share Addition

BlackRock, Inc. has increased its stake in Zentalis Pharmaceuticals (ZNTL) by purchasing 2,441,077 additional shares, bringing its total ownership to 5.20% of the company's outstanding shares. This strategic move, executed at $4.85 per share, reflects BlackRock's confidence in the clinical-stage biopharmaceutical company's long-term prospects, …

Zensar Technologies Q1 Results: Earnings call transcript released

Citizens Bank to distribute Shakespeare in the Park tickets at Woodside branch tomorrow

Citizens Bank will distribute free Shakespeare in the Park tickets at its Woodside branch on Thursday, August 6, making the popular "The Winter's Tale" production more accessible. This event is part of a larger initiative by The Public Theater and Citizens Bank to offer …

Earnings call transcript: Azenta tops Q3 2026 estimates, shares edge higher

Azenta Q3 2026 EPS Tops Expectations, Revenue Up 12%

Azenta, Inc. reported strong Q3 2026 results, with Non-GAAP Diluted EPS of $0.16, significantly exceeding Wall Street's estimate of $0.12. The company's revenue rose 12.0% year-over-year to $161.2M, primarily driven by impressive organic growth of 9.0% and strong performance in its Sample Management Solutions …

AZN rebounds after report dismisses AstraZeneca-Bristol Myers merger speculation

Astra Zeneca logo on building ©Adobe Stock Images AstraZeneca (NASDAQ:AZN) shares climbed around 6% on Wednesday after Reuters reported that there are "no discussions" between the company and Bristol Myers Squibb (NYSE:BMY) regarding a potential merger, contradicting recent speculation that had unsettled investors. The …

Exclusive-'No discussions' over AstraZeneca-Bristol Myers deal, senior source says

By Maggie Fick and Sabrina Valle Aug 5 (Reuters) - There are "no discussions" ongoing between AstraZeneca and Bristol Myers Squibb over a ‌potential deal, a senior source close to the matter told ‌Reuters on Wednesday, quashing the prospect of a mooted mega merger …

Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls

Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top …

AZN spikes 6% after report it denies AstraZeneca-BMS merger talks

Investing.com - AstraZeneca shares surged approximately 6% on Wednesday after a senior source told Reuters there are "no discussions" between AstraZeneca and Bristol Myers Squibb over a potential deal, flatly quashing reports of a merger that would have created a pharmaceutical giant worth nearly …

AstraZeneca climbs Wednesday, outperforms market

Shares of AstraZeneca PLC (AZN) rose 2.52% to £120.36 on Wednesday, outperforming the FTSE 100 Index, which increased by 0.08%. The company's stock closed 23.49% below its 52-week high of £157.32.

AstraZeneca Stock Drops 7% as Merger Talks With Bristol Myers Squibb Surface

AstraZeneca and Bristol Myers Squibb never held merger discussions and are not in talks now, a senior source close to the matter told Reuters on Wednesday. "There is no deal between AstraZeneca and BMS. There never was a deal to be done, and there …

Citizens Financial Group (CFG) Stock Faces Valuation Friction After Strong Q2

Citizens Financial Group (CFG) reported a strong Q2 2026 with significant increases in revenue, net income, and EPS, along with improved net interest margin. Despite these robust results and progress in diversification and efficiency, the stock's valuation faces friction due to its P/E ratio …

Azenta, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:AZTA) 2026-08-05

AstraZeneca PLC Stock (AZN) Moved Up by 4.30% on Aug 5: A Full Analysis

Azenta, Inc. (AZTA) SVP acquires 335 shares via 2017 stock purchase plan

Ephraim Starr, SVP, General Counsel & Secretary of Azenta, Inc. (AZTA), purchased 335 shares of common stock on July 31, 2026, at $24.1676 per share through the company's 2017 Employee Stock Purchase Plan. This transaction, which was exempt from Section 16(b), increased his direct …

Zenas BioPharma (ZBIO) Projected to Release Quarterly Earnings on Tuesday

Zenas BioPharma (ZBIO) is expected to announce its Q2 2026 earnings before market open on Tuesday, August 11th. Analysts forecast a loss of $1.12 per share on $15 million in revenue, following a Q1 loss of $1.46 per share which slightly beat estimates. The …

Earnings Flash (AZTA) Azenta, Inc. Posts Q3 Adjusted EPS $0.16 per Share

Azenta, Inc. (AZTA) announced its Q3 adjusted EPS of $0.16 per share, surpassing FactSet's estimate of $0.11. The company also reported Q3 revenue of $161.2 million, exceeding FactSet's estimate of $149.3 million. This financial update indicates a stronger performance than anticipated by analysts for …

Azenta reports Q3 fiscal 2026: Revenue $161M, Adjusted EBITDA $18.5M, Non-GAAP EPS $0.16

Azenta (AZTA) reported its fiscal Q3 2026 results with revenue of $161.2 million and non-GAAP diluted EPS of $0.16. The company achieved an adjusted EBITDA of $18.5 million, representing an 11.4% margin, and noted 9% organic revenue growth year over year. Azenta also reiterated …

Azenta Reports Third Quarter Results for Fiscal 2026, Ended June 30, 2026.

Azenta, Inc. reported its third-quarter financial results for fiscal year 2026, exceeding expectations with continued strength in recurring revenue and a modest improvement in Multiomics in North America. The company's revenue from continuing operations was $161 million, an increase of 12% year-over-year, and it …

ZenaTech stock rises after filing wildfire drone patents By Investing.com

ZenaTech shares increased by 5.9% after the company filed five provisional patents for acoustic fire suppression and aerial wildfire assessment technologies, intended for its ZenaDrone 1000 platform. These soundwave-based solutions aim to enhance rapid initial attack and emergency response for wildfires, using low-frequency sound …

Azenta earnings on deck: Can life sciences firm return to profit?

Azenta Inc. is scheduled to report its fiscal third-quarter earnings, with analysts expecting a return to profitability at $0.10 per share on $149.29 million in revenue, a significant improvement from the previous quarter's loss. Investors will be closely watching for sustained profitability, North American …

Citizens Financial Group Inc. stock rises Tuesday, still underperforms market

Shares of Citizens Financial Group Inc. (CFG) increased by 1.35% on Tuesday, closing at $73.68. Despite this rise, the stock underperformed the broader market, as the S&P 500 Index and Dow Jones Industrial Average both saw larger gains. This marks the second consecutive day …

ZenaTech Files Five Patents for ZenaDrone’s Acoustic Drone Solution for Wildfire Suppression, Positioning

ZenaTech has filed five provisional patents for its ZenaDrone's acoustic drone solution, aimed at wildfire suppression and aerial assessment. This innovative technology uses soundwaves to suppress fires, offering a new approach compared to traditional water and chemical methods, and is intended for integration with …

Bristol Myers Squibb Potential Deal With AstraZeneca Seen Unlikely as Shareholder Views Diverge, RBC Says

Bristol Myers Squibb's (BMY) reported merger discussions with AstraZeneca (AZN) will unlikely result PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? …

First Citizens Bank Introduces Working Capital Finance Group

First Citizens Bank has launched a new "Working Capital Finance" group, combining its factoring, asset-based lending, supply chain finance, international factoring, and receivables purchasing businesses. This initiative aims to provide middle market companies with an expanded suite of financing and treasury solutions to manage …

Brokers split on AstraZeneca merger talk as shares recover some ground

Brokers split on AstraZeneca merger talk as shares recover some ground Proactive uses images sourced from Shutterstock Citi has told clients that a large chunk of deal risk is already in AstraZeneca PLC's (LSE:AZN, NASDAQ:AZN) share price after Monday's sharp fall, while Deutsche Bank …

ZenaTech files five patents for drone wildfire technology By Investing.com

ZenaTech, Inc. has filed five provisional patents for acoustic fire suppression and aerial wildfire assessment technologies to be used with its ZenaDrone 1000 platform. These soundwave-based solutions are designed to complement traditional firefighting methods, especially in areas where conventional suppression is not feasible, such …

Sound Waves, Not Water: ZenaTech Develops Firefighting Drones

ZenaTech (Nasdaq: ZENA) has filed five U.S. provisional patents for an acoustic fire suppression and aerial wildfire assessment system, integrated with its ZenaDrone 1000 platform. This technology uses low-frequency sound waves to disrupt flames, offering an alternative to traditional water or chemical methods, especially …

AstraZeneca (LSE:AZN) Is In Merger Talks With Bristol Myers For $400 Billion

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. AstraZeneca (LSE:AZN) is reported to be in advanced merger talks with Bristol Myers Squibb. The potential deal could create a combined pharmaceutical company valued at about US$400b. …

AstraZeneca-Bristol Myers: The Floodgates for Biotech Mergers Are Open

Even if a megamerger fails to materialize, investors stand to benefit from a wave of M&A activity in the biopharma sector. Continue Reading

Citizens & Northern Corp's Dividend Analysis

Citizens & Northern Corp (NASDAQ: CZNC) announced a $0.28 per share dividend, with an ex-dividend date of August 3, 2026. The company has a consistent dividend payment record since 1993, offering a 4.40% trailing and forward dividend yield. However, its dividend growth has been …

SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies

BOSTON and ROLLE, Switzerland, Aug. 4, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH) today announced a new global collaboration to develop, validate, and deploy two companion diagnostics (CDx) supporting precision oncology therapies with AstraZeneca (LSE/STO/NYSE: AZN).SOPHiA GENETICS Logo This multi-year collaboration agreement will advance …

Citizens cuts MFA Financial stock price target on credit stress By Investing.com

Citizens has lowered its price target for MFA Financial Inc. (NYSE:MFA) to $11.00 from $11.50 due to increased credit stress, particularly in its transitional loan portfolios. Despite the reduced price target, Citizens maintained a Market Outperform rating. The company reported Q1 distributable EPS of …

Levi & Korsinsky Urges Zenas BioPharma, Inc. (ZBIO) Shareholders to Act Before Lead Plaintiff Deadline June 16, 2025

Levi & Korsinsky is urging shareholders of Zenas BioPharma, Inc. (ZBIO) to act before the lead plaintiff deadline of June 16, 2025, in a lawsuit alleging that the company made false statements regarding its financial runway following its September 2024 IPO. The lawsuit claims …

Why (SRZN) Price Action Is Critical for Tactical Trading

This article analyzes Surrozen Inc. (NASDAQ: SRZN) focusing on its price action for tactical trading. It highlights mixed sentiment across different timeframes, with positive near-term sentiment potentially eroding a mid-term weak bias within a long-term strong context. The analysis also provides AI-generated institutional trading …